ARTICLE | Clinical News
VT-1161 regulatory update
October 17, 2016 7:00 AM UTC
FDA granted Qualified Infectious Disease Product (QIDP) designation to VT-1161 from Viamet to treat recurrent vulvovaginal candidiasis. VT-1161 is in a Phase IIb trial for the indication (see BioCentu...